Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMIPREP: Microfat and PRP for Radiocarpal Osteoarthritis
NCT03164122Phase 2Completed
- Sponsor
- Assistance Publique-Hôpitaux de Marseille
- Start
- May 2017
- Primary completion
- Jun 2018
- Modality
- Adoptive Cell Transfer
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of autologous microfat and autologous platelet-rich plasma in osteoarthritis of the wrist, sponsored by Assistance Publique-Hôpitaux de Marseille. Primary endpoint: Safety at 1 month. Started May 2017; status: completed.
02
Drugs
autologous microfatautologous platelet-rich plasma
03
Conditions
osteoarthritis of the wrist
Beyond the preview
Go deeper on NCT03164122.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03164122.